Tina Barajas
Family · Jasper, GANPI 1215522990
Payments from drug & device makers
Across 158 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$288
- Novo Nordisk$221
- Axsome Therapeutics, Inc.$193
- Insmed, Inc.$188
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$136
- Pfizer$122
- plus $2K from 35 others
What the payments were for
- Food & beverage$2,68797%
- Education$843%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,771 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 79 | $111,626 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 16 | $62,486 |
| EliquisApixaban | 60 | $55,135 |
| JardianceEmpagliflozin | 30 | $35,144 |
| XareltoRivaroxaban | 26 | $25,136 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $21,154 |
| LinzessLinaclotide | 14 | $18,637 |
| FarxigaDapagliflozin Propanediol | 12 | $7,538 |
| MyrbetriqMirabegron | 16 | $7,085 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $6,318 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $5,737 |
| Dexlansoprazole DrDexlansoprazole | 15 | $4,239 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,788 |
| SynthroidLevothyroxine Sodium | 36 | $3,100 |
| Rosuvastatin Calcium | 204 | $2,820 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $221 | $111,62679 claims |
| GileadBiktarvy | $16 | $62,48616 claims |
| PfizerEliquis | $122 | $55,13560 claims |
| Boehringer IngelheimJardiance | $20 | $35,14430 claims |
| AbbVieLinzess, Synthroid | $288 | $21,73750 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $103 | $21,15412 claims |
| AstraZenecaFarxiga | $121 | $7,53812 claims |
| Astellas Pharma US IncMyrbetriq | $40 | $7,08516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Jasper
- Emily CumminsJasper$30K
- Camlyn LoweJasper$14K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.